Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Stay ahead in 2025 with the latest biotech deals. Discover key collaborations, M&A, and strategic moves shaping the ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles ...

The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Senators pressed Robert F. Kennedy Jr. on his past vaccine and abortion remarks in the first of two days of hearings before ...

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of ...

Danaher on Wednesday missed Wall Street estimates for fourth-quarter profit due to soft demand for tools and services used in drug development by its biotech and pharmaceutical clients.

Danaher reported higher earnings and revenue in the fourth quarter from gains in its life-sciences and biotechnology units, though it expects the top line to decline in the first quarter. The ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...